An analysis of tralokinumab-ldrm, an FDA-approved treatment for atopic dermatitis.

Published Date: 01 Feb 2024

Weily Soong, MD, discusses the FDA-approved treatment tralokinumab-ldrm for patients with moderate-to-severe atopic dermatitis who are between the ages of 12 and 17 in this Q&A session with Contemporary Pediatrics.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

4.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

5.

Beyond What Is Visible in Myelofibrosis?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot